385 related articles for article (PubMed ID: 34301194)
21. Clinical and genetic determinants of ovarian metastases from colorectal cancer.
Ganesh K; Shah RH; Vakiani E; Nash GM; Skottowe HP; Yaeger R; Cercek A; Lincoln A; Tran C; Segal NH; Reidy DL; Varghese A; Epstein AS; Sonoda Y; Chi D; Guillem J; Temple L; Paty P; Hechtman J; Shia J; Weiser M; Aguilar JG; Kemeny N; Berger MF; Saltz L; Stadler ZK
Cancer; 2017 Apr; 123(7):1134-1143. PubMed ID: 27875625
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of Kirsten rat sarcoma viral oncogene homolog mutations in resected lung adenocarcinoma differs according to clinical features.
Ma Z; Zhang Y; Deng C; Fu F; Deng L; Li Y; Chen H
J Thorac Cardiovasc Surg; 2022 Jan; 163(1):e73-e85. PubMed ID: 32739163
[TBL] [Abstract][Full Text] [Related]
23. BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis.
Chen D; Huang JF; Liu K; Zhang LQ; Yang Z; Chuai ZR; Wang YX; Shi DC; Huang Q; Fu WL
PLoS One; 2014; 9(3):e90607. PubMed ID: 24594804
[TBL] [Abstract][Full Text] [Related]
24. Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis.
Passiglia F; Bronte G; Bazan V; Galvano A; Vincenzi B; Russo A
Crit Rev Oncol Hematol; 2016 Mar; 99():150-7. PubMed ID: 26775732
[TBL] [Abstract][Full Text] [Related]
25. Different oncological features of colorectal cancer codon-specific
Ahn HM; Kim DW; Oh HJ; Kim HK; Lee HS; Lee TG; Shin HR; Yang IJ; Lee J; Suh JW; Oh HK; Kang SB
World J Gastroenterol; 2023 Aug; 29(32):4883-4899. PubMed ID: 37701134
[TBL] [Abstract][Full Text] [Related]
26. The impact of somatic SMAD4 mutations in colorectal liver metastases.
Xourafas D; Mizuno T; Cloyd JM
Chin Clin Oncol; 2019 Oct; 8(5):52. PubMed ID: 31500428
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and prognostic significance of SMAD4 in non-small cell lung cancer: A meta-analysis and database validation.
Li Z; Huang Y; Zhou R; Li Z; Yan Q
Medicine (Baltimore); 2023 Jul; 102(29):e34312. PubMed ID: 37478236
[TBL] [Abstract][Full Text] [Related]
28. Prognostic and clinicopathological significance of SNHG6 in human cancers: a meta-analysis.
Zhao S; Zhu H; Jiao R; Wu X; Ji G; Zhang X
BMC Cancer; 2020 Jan; 20(1):77. PubMed ID: 32000704
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis.
Liu Y; Tang W; Wang J; Xie L; Li T; He Y; Qin X; Li S
Diagn Pathol; 2013 Nov; 8():181. PubMed ID: 24188373
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M
PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310
[TBL] [Abstract][Full Text] [Related]
31. SMAD4 alteration associates with invasive-front pathological markers and poor prognosis in colorectal cancer.
Oyanagi H; Shimada Y; Nagahashi M; Ichikawa H; Tajima Y; Abe K; Nakano M; Kameyama H; Takii Y; Kawasaki T; Homma KI; Ling Y; Okuda S; Takabe K; Wakai T
Histopathology; 2019 May; 74(6):873-882. PubMed ID: 30636020
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
33. PD-L1 Overexpression on Tumor-Infiltrating Lymphocytes Related to Better Prognosis of Colorectal Cancer.
Wang JL; Yu T; Sun TT; Feng Y; Xiong H; Fang JY
Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337839
[TBL] [Abstract][Full Text] [Related]
34. Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial.
Stahler A; Stintzing S; von Einem JC; Westphalen CB; Heinrich K; Krämer N; Michl M; Modest DP; von Weikersthal LF; Decker T; Kiani A; Heintges T; Kahl C; Kullmann F; Scheithauer W; Moehler M; Kaiser F; Kirchner T; Jung A; Heinemann V
Eur J Cancer; 2020 Sep; 137():250-259. PubMed ID: 32810748
[TBL] [Abstract][Full Text] [Related]
35. Clinical Effect of Driver Mutations of
Gu Y; Ji Y; Jiang H; Qiu G
Genet Test Mol Biomarkers; 2020 Dec; 24(12):777-788. PubMed ID: 33347393
[No Abstract] [Full Text] [Related]
36. LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis.
Agbana YL; Abi ME; Ni Y; Xiong G; Chen J; Yun F; Yi Z; Zhang Q; Yang Z; Kuang Y; Zhu Y
BMC Cancer; 2020 Jul; 20(1):682. PubMed ID: 32698787
[TBL] [Abstract][Full Text] [Related]
37. Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran.
Yari A; Samoudi A; Afzali A; Karam ZM; Karimaldini NK; Abadi MFS; Ziasistani M; Zangouey MR; Dabiri S
J Gastrointest Cancer; 2021 Jun; 52(2):557-568. PubMed ID: 32495109
[TBL] [Abstract][Full Text] [Related]
38. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
39. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
40. CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer.
Smeby J; Sveen A; Merok MA; Danielsen SA; Eilertsen IA; Guren MG; Dienstmann R; Nesbakken A; Lothe RA
Ann Oncol; 2018 May; 29(5):1227-1234. PubMed ID: 29518181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
